These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Simvastatin attenuates plaque inflammation: evaluation by fluorodeoxyglucose positron emission tomography. Tahara N; Kai H; Ishibashi M; Nakaura H; Kaida H; Baba K; Hayabuchi N; Imaizumi T J Am Coll Cardiol; 2006 Nov; 48(9):1825-31. PubMed ID: 17084257 [TBL] [Abstract][Full Text] [Related]
10. Variability and uncertainty of 18F-FDG PET imaging protocols for assessing inflammation in atherosclerosis: suggestions for improvement. Huet P; Burg S; Le Guludec D; Hyafil F; Buvat I J Nucl Med; 2015 Apr; 56(4):552-9. PubMed ID: 25722452 [TBL] [Abstract][Full Text] [Related]
11. Relationships among regional arterial inflammation, calcification, risk factors, and biomarkers: a prospective fluorodeoxyglucose positron-emission tomography/computed tomography imaging study. Rudd JH; Myers KS; Bansilal S; Machac J; Woodward M; Fuster V; Farkouh ME; Fayad ZA Circ Cardiovasc Imaging; 2009 Mar; 2(2):107-15. PubMed ID: 19808576 [TBL] [Abstract][Full Text] [Related]
12. In Vivo ¹⁸F-FDG-PET Imaging in Mouse Atherosclerosis. Mateo J; Bilbao I; Vaquero JJ; Ruiz-Cabello J; España S Methods Mol Biol; 2015; 1339():377-86. PubMed ID: 26445805 [TBL] [Abstract][Full Text] [Related]
13. Imaging of atherosclerotic aorta of rabbit model by detection of plaque inflammation with fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography. Zhao QM; Feng TT; Zhao X; Xu ZM; Liu Y; Li DP; Li LQ; Su G; Zhang XX Chin Med J (Engl); 2011 Mar; 124(6):911-7. PubMed ID: 21518602 [TBL] [Abstract][Full Text] [Related]
14. Emerging role of FDG-PET/CT in assessing atherosclerosis in large arteries. Chen W; Bural GG; Torigian DA; Rader DJ; Alavi A Eur J Nucl Med Mol Imaging; 2009 Jan; 36(1):144-51. PubMed ID: 18982324 [TBL] [Abstract][Full Text] [Related]
15. Non-FDG imaging of atherosclerosis: will imaging of MMPs assess plaque vulnerability? Hermann S; Starsichova A; Waschkau B; Kuhlmann M; Wenning C; Schober O; Schäfers M J Nucl Cardiol; 2012 Jun; 19(3):609-17. PubMed ID: 22477642 [TBL] [Abstract][Full Text] [Related]
16. Higher reliability of 18F-FDG target background ratio compared to standardized uptake value in vulnerable carotid plaque detection: a pilot study. Niccoli Asabella A; Ciccone MM; Cortese F; Scicchitano P; Gesualdo M; Zito A; Di Palo A; Angiletta D; Regina G; Marzullo A; Rubini G Ann Nucl Med; 2014 Jul; 28(6):571-9. PubMed ID: 24737136 [TBL] [Abstract][Full Text] [Related]
17. (18)Fluorodeoxyglucose positron emission tomography imaging of atherosclerotic plaque inflammation is highly reproducible: implications for atherosclerosis therapy trials. Rudd JH; Myers KS; Bansilal S; Machac J; Rafique A; Farkouh M; Fuster V; Fayad ZA J Am Coll Cardiol; 2007 Aug; 50(9):892-6. PubMed ID: 17719477 [TBL] [Abstract][Full Text] [Related]